Free Trial
OTCMKTS:BICX

Biocorrx Q1 2026 Earnings Results & Report

Biocorrx logo
$0.21 0.00 (0.00%)
As of 11/13/2026 10:26 AM Eastern

Biocorrx beat analyst earnings expectations but missed on revenue in its Q1 2026 results, released May 15, 2026. The company reported EPS of -$0.03 versus the -$0.06 consensus estimate, while revenue of $215 thousand fell short of the $220 thousand estimate by $5.00 thousand.

Earnings Announcement Details

Quarter
Q1 2026
Report Date
Time
After Market Closes

Biocorrx EPS Results

Actual EPS
-$0.03
Consensus EPS
-$0.06
Beat/Miss
Beat by +$0.03
One Year Ago EPS
N/A
EPS Beat Rate
3 of last 4 quarters

Biocorrx Revenue Results

Actual Revenue
$215 thousand
Expected Revenue
$220 thousand
Beat/Miss
Missed by -$5.00 thousand
YoY Revenue Growth
N/A

Upcoming Earnings

Biocorrx's next earnings date is estimated for Tuesday, November 17, 2026, based on past reporting schedules.

Conference Call Resources

Biocorrx Q1 2026 Earnings FAQ

Biocorrx (OTCMKTS:BICX) reported earnings of -$0.03 per share for Q1 2026, beating the consensus estimate of -$0.06. The report was announced on Friday, May 15, 2026.

Biocorrx reported revenue of $215 thousand for Q1 2026, against a consensus estimate of $220 thousand.

Biocorrx's next earnings date is estimated for Tuesday, November 17, 2026. MarketBeat tracks confirmed and estimated earnings dates for Biocorrx on the company's earnings history page.

Biocorrx Earnings Headlines

Biocorrx (BICX) Projected to Release Quarterly Earnings on Tuesday
BioCorRx Inc
Your Social Security check is scheduled for a 22% cut
The U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt death spiral. Interest payments alone now top a trillion dollars a year. The Social Security trust fund is projected to run dry by 2032, which could trigger an automatic 22% cut to benefits. Between 2020 and 2022, the Fed expanded the money supply by 41%. A free 27 page report breaks down these numbers in plain English, including what central banks have been doing with gold.tc pixel
BioCorRx Inc.
See More Biocorrx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Biocorrx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biocorrx and other key companies, straight to your email.

About Biocorrx

Biocorrx (OTCMKTS:BICX), Inc. is a healthcare company focused on substance-use-disorder treatment and related products. Its BioCorRx Recovery Program is an outpatient approach that combines medication-assisted treatment with counseling and ongoing support for people seeking treatment for alcohol or opioid dependence.

The company has also pursued pharmaceutical products intended to support addiction treatment, including long-acting formulations. Its business includes developing treatment offerings and working to make them available through healthcare providers.

BioCorRx has also offered UnCraveRx, a medically supervised weight-management program. Its activities are centered on treatment and support services rather than traditional pharmaceutical manufacturing or general medical care.

View Biocorrx Profile